Horan Capital Management Has Raised Gilead Sciences (GILD) Holding By $2.01 Million; Greatbatch, Inc. (GB) Had 2 Bulls

December 11, 2017 - By Adrian Mccoy

Horan Capital Management increased Gilead Sciences Inc (GILD) stake by 11.45% reported in 2017Q2 SEC filing. Horan Capital Management acquired 28,734 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Horan Capital Management holds 279,734 shares with $19.80 million value, up from 251,000 last quarter. Gilead Sciences Inc now has $96.95B valuation. The stock increased 2.06% or $1.5 during the last trading session, reaching $74.22. About 7.91M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since December 11, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 3 analysts covering Greatbatch Inc (NYSE:GB), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Greatbatch Inc had 6 analyst reports since August 28, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Friday, August 28 by KeyBanc Capital Markets. KeyBanc Capital Markets maintained it with “Overweight” rating and $51 target in Friday, March 11 report. The stock of Greatbatch, Inc. (NYSE:GB) has “Sector Perform” rating given on Tuesday, October 6 by RBC Capital Markets. See Greatbatch, Inc. (NYSE:GB) latest ratings:

The stock increased 0.00% or $0.63 during the last trading session, reaching $30.93. It is down 0.00% since December 11, 2016 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 1.03 in Q2 2017. Its up 0.10, from 0.93 in 2017Q1. It is positive, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. North Tide Cap Ltd Liability Corp holds 15.75% or 1.00 million shares. 257,351 are held by Howland Lc. Washington Tru Bank & Trust reported 2,767 shares. First Mercantile holds 0.45% in Gilead Sciences, Inc. (NASDAQ:GILD) or 35,249 shares. Homrich Berg holds 6,666 shares. Violich Cap Management reported 85,282 shares. Wilsey Asset Mgmt has invested 6.17% in Gilead Sciences, Inc. (NASDAQ:GILD). Signaturefd Ltd Liability holds 4,844 shares or 0.05% of its portfolio. 4,248 were reported by Empirical Services Limited Liability. Cibc Asset Mngmt Inc holds 165,663 shares or 0.08% of its portfolio. International Investors has invested 0.57% in Gilead Sciences, Inc. (NASDAQ:GILD). Evergreen Cap Limited Liability Corp reported 0.49% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Investment House Limited Liability, a California-based fund reported 81,240 shares. Cypress Asset Mngmt Tx, Texas-based fund reported 26,215 shares. Abner Herrman Brock Limited Liability reported 10,202 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. As per Wednesday, October 28, the company rating was maintained by Maxim Group. The firm has “Hold” rating given on Tuesday, October 3 by Needham. The company was maintained on Thursday, October 19 by Leerink Swann. As per Tuesday, May 30, the company rating was maintained by Cowen & Co. Argus Research upgraded the stock to “Buy” rating in Thursday, August 31 report. Maxim Group maintained the stock with “Hold” rating in Tuesday, May 30 report. Argus Research downgraded the shares of GILD in report on Friday, July 29 to “Hold” rating. The company was initiated on Wednesday, June 1 by Gabelli. Morgan Stanley maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, October 6 with “Equal-Weight” rating. Oppenheimer maintained the stock with “Outperform” rating in Tuesday, October 20 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com